1-(2,6-Dichloropyridin-4-yl)ethanone, 95.0%, 250mg

4-Prop-2-ynyloxy-benzaldehyde, 95.0%, 25g

4-(5-Fluoro-2-nitrophenyl)morpholine, 97.0%, 1g

Methyl 2-oxopiperidine-4-carboxylate, 95.0%, 5g

Bicyclo[2.2.2]octane-2,3,5,6-tetracarboxylic 2,3:5,6-Dianhydride>98.0%(T)5g

Filtration unit with cellulose nitrate membrane Pore size 0.8 μm, with grid, 250 ml, 250 ml, 50 mm, 12 Piece(s)

4-(chloromethyl)-2,6-dihydroxybenzaldehyde, 95.0%, 500mg

[(3-ethyl-1,2,4-oxadiazol-5-yl)methyl]amine trifluoroacetate, 95.0%, 1g

(S)-3-Amino-1-N-Cbz-pyrrolidine hydrochloride, 98.0%, 1g

(2,3-Dihydro-benzo[1,4]dioxin-6-ylmethyl)-methyl-amine, 95.0%, 250mg

Carbolic fuchsine solution, 500 ml

2-(4-(4-Chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid, 98%, 100mg

2-Bromonaphthalene-1,3,4,5,6,7,8-d7, 100mg